Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2012; 18(33): 4542-4548
Published online Sep 7, 2012. doi: 10.3748/wjg.v18.i33.4542
Published online Sep 7, 2012. doi: 10.3748/wjg.v18.i33.4542
Table 1 Antibiotic regimens suggested by our unit and eradication rates per protocol
Patients | H. pylori eradicated and eradication rate per protocol(95% CI) | Patientstreated and cumulative effect (95% CI) | |
First-line: | 2428 | 1814 | |
PPI b.i.d. + amoxicillin 1 g b.i.d. + clarithromycin 500 mg b.i.d. for 7 d | 74.7 (72.7-76.4) | ||
Second-line: | 326 | 278 | 2140 |
PPI b.i.d. + amoxicillin 1 g b.i.d. + tinidazole 500 mg b.i.d. for 14 d | 85.3 (81.1-89.1) | 97.8 (97.1-98.4) | |
Third-line: | 19 | 17 | 2111 |
PPI b.i.d. + amoxicillin 1 g b.i.d. + levofloxacin 250 mg b.i.d. for 14 d | 89.5 (74.9-103) | 99.9 (99.8-100) |
-
Citation: Sereni G, Azzolini F, Camellini L, Formisano D, Decembrino F, Iori V, Tioli C, Cavina M, Di Mario F, Bedogni G, Sassatelli R. Efficacy of a therapeutic strategy for eradication of
Helicobacter pylori infection. World J Gastroenterol 2012; 18(33): 4542-4548 - URL: https://www.wjgnet.com/1007-9327/full/v18/i33/4542.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i33.4542